Abiopharma

News list

Gertsch Timothy 🟡 adjusted position in 9.7K shares of agilon health, inc. (AGL) at $9.75 Transaction Date: Apr 01, 2026 | Filing ID: 023766

Full text

News bot April 3, 2026, 11:38 p.m.
🔍 Gertsch Timothy (Executive)

Company: agilon health, inc. (AGL)

Report Date: 2026-04-01
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 10,000
- Total shares sold: 266
Detailed Transactions and Holdings:
- Sold 266 shares of Common Stock at $9.75 per share (Direct)
  Date: 2026-04-01 | Code: F | equity_swap_involved: 0 | shares_owned_after: 4,324.00 | transaction_form_type: 4 | Footnotes: F1, F2
- Acquired 10,000 shares of Common Stock (Direct)
  Date: 2026-04-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 14,324.00 | transaction_form_type: 4 | Footnotes: F3, F4
Footnotes:
- F1: Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the restricted stock units and does not represent a sale.
- F2: The amount of securities beneficially owned following the reported transaction reflects the 1 for 25 reverse stock split of the Issuer's issued and outstanding common stock effective March 30, 2026.
- F3: Restricted stock units that vest in three equal installments on each anniversary of April 1, 2026, subject to continued employment.
- F4: Includes restricted stock units.